1. Home
  2. LSTA vs SCOR Comparison

LSTA vs SCOR Comparison

Compare LSTA & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • SCOR
  • Stock Information
  • Founded
  • LSTA 1980
  • SCOR 1999
  • Country
  • LSTA United States
  • SCOR United States
  • Employees
  • LSTA N/A
  • SCOR N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • SCOR Business Services
  • Sector
  • LSTA Health Care
  • SCOR Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • SCOR Nasdaq
  • Market Cap
  • LSTA 31.2M
  • SCOR 34.7M
  • IPO Year
  • LSTA N/A
  • SCOR 2007
  • Fundamental
  • Price
  • LSTA $2.67
  • SCOR $7.98
  • Analyst Decision
  • LSTA Strong Buy
  • SCOR Buy
  • Analyst Count
  • LSTA 1
  • SCOR 3
  • Target Price
  • LSTA $15.00
  • SCOR $12.83
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • SCOR 43.2K
  • Earning Date
  • LSTA 02-27-2025
  • SCOR 03-05-2025
  • Dividend Yield
  • LSTA N/A
  • SCOR N/A
  • EPS Growth
  • LSTA N/A
  • SCOR N/A
  • EPS
  • LSTA N/A
  • SCOR N/A
  • Revenue
  • LSTA N/A
  • SCOR $356,212,000.00
  • Revenue This Year
  • LSTA N/A
  • SCOR N/A
  • Revenue Next Year
  • LSTA N/A
  • SCOR $2.92
  • P/E Ratio
  • LSTA N/A
  • SCOR N/A
  • Revenue Growth
  • LSTA N/A
  • SCOR N/A
  • 52 Week Low
  • LSTA $2.19
  • SCOR $4.89
  • 52 Week High
  • LSTA $4.20
  • SCOR $20.42
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • SCOR 66.50
  • Support Level
  • LSTA $2.45
  • SCOR $6.82
  • Resistance Level
  • LSTA $2.74
  • SCOR $7.49
  • Average True Range (ATR)
  • LSTA 0.32
  • SCOR 0.59
  • MACD
  • LSTA -0.05
  • SCOR 0.18
  • Stochastic Oscillator
  • LSTA 16.48
  • SCOR 88.87

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.

Share on Social Networks: